Vivus Inc's ability to collect its outstanding accounts receivable from its corporate clients, has improved in the first quarter 2020 to a ratio of 3.06, this is below the company average, and notable indication of worsening business environment. Average receivable collection period, for the Vivus Inc in Mar 31 2020 quarter, has decreased to 119 days, compared to 125 days, in the Dec 31 2019 quarter.

If we take a look into Healthcare sector 503 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Mar 31 2020 from 3039 to 3797.

What is Receivable Turnover Ratio?
What is Vivus Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

VVUS Receivables Turnover Ratio	(Mar 31 2020) I. Quarter	(Dec 31 2019) IV. Quarter	(Sep 30 2019) III. Quarter	(Jun 30 2019) II. Quarter	(Mar 31 2019) I. Quarter
Y / Y Receivable Change	0.69 %	-12.77 %	1.86 %	121.91 %	117.47 %
Y / Y Revenue Change	21.58 %	-14.22 %	-0.65 %	22.93 %	35.68 %
Receivable Turnover Ratio (TTM)	3.06	2.92	2.94	2.96	3.27
VVUS's Total Ranking	# 3797	# 3039	# 3793	# 3234	# 3036
Accounts Receivable average collection period days	119	125	124	123	112
Seq. Receivable Change	10.68 %	-7.18 %	-2.05 %	0.06 %	-4.12 %
Seq. Revenue Change	13.78 %	-3.98 %	-2.28 %	13.9 %	-19.73 %

Receivable Turnover Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 206
Healthcare Sector	# 504
Overall Market	# 3797

Receivable Turnover Ratio Statistics
High	Average	Low
13.46	6.67	2.92
(Jun 30 2017)		(Dec 31 2019)

VVUS Company Profile • Back to VVUS Efficiency Comparisons • Compare VVUS Receivables Turnover Ratio to its Competitors

Financial Statements
Vivus Inc's Accounts Receivable	$ 25 Millions	Visit VVUS's Balance sheet
Vivus Inc's Sales TTM	$ 73 Millions	Visit VVUS's Income Statement
Sources of VVUS's Revenues		Visit VVUS's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
VVUS's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
VVUS's Growth Rates	VVUS's Roa	VVUS's Inventory Turnover Ratio	VVUS's Dividend Comparisons
VVUS's Profitability Ratios	VVUS's Roi	VVUS's Asset Turnover Ratio	VVUS's Dividend Growth
VVUS's Valuation Ratios	VVUS's Roe	VVUS's Financial Strength Ratios	VVUS's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Mar 31 2020, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Mar 31 2020	Receivable at quarter ending Mar 31 2020
Nrc Health	8.14	$ 130.362 Millions	$ 16.013 Millions
Tandem Diabetes Care Inc	8.12	$ 394.236 Millions	$ 48.578 Millions
Vertex Pharmaceuticals Inc	8.08	$ 4,819.493 Millions	$ 596.751 Millions
Geovax Labs Inc	8.07	$ 1.528 Millions	$ 0.189 Millions
Novaccess Global Inc	8.07	$ 1.572 Millions	$ 0.195 Millions
Pacific Biosciences Of California Inc	8.06	$ 90.064 Millions	$ 11.170 Millions
Lantheus Holdings Inc	8.05	$ 351.531 Millions	$ 43.643 Millions
Invitae Corporation	8.01	$ 240.519 Millions	$ 30.040 Millions
Option Care Health Inc	8.01	$ 2,233.616 Millions	$ 278.999 Millions
Puma Biotechnology Inc	7.95	$ 224.410 Millions	$ 28.242 Millions
Invacare Holdings Corporation	7.94	$ 922.985 Millions	$ 116.205 Millions
Nuwellis Inc	7.94	$ 5.926 Millions	$ 0.747 Millions
Amedisys Inc	7.92	$ 1,979.978 Millions	$ 250.131 Millions
Pro dex Inc	7.91	$ 30.712 Millions	$ 3.882 Millions
Clovis Oncology inc	7.83	$ 152.452 Millions	$ 19.459 Millions
Shockwave Medical Inc	7.83	$ 50.855 Millions	$ 6.495 Millions
Alphatec Holdings Inc	7.83	$ 118.987 Millions	$ 15.200 Millions
Viemed Healthcare Inc	7.82	$ 89.104 Millions	$ 11.395 Millions
Intellipharmaceutics International Inc	7.82	$ 3.515 Millions	$ 0.450 Millions
Inspire Medical Systems inc	7.81	$ 87.147 Millions	$ 11.153 Millions
Encision Inc	7.81	$ 7.670 Millions	$ 0.982 Millions
Vaso Corporation	7.81	$ 77.505 Millions	$ 9.929 Millions
Atrion Corporation	7.77	$ 157.046 Millions	$ 20.209 Millions
American Renal Associates Holdings Inc	7.71	$ 823.942 Millions	$ 106.872 Millions
Wright Medical Group N v	7.70	$ 1,059.020 Millions	$ 137.471 Millions
Boston Scientific Corporation	7.68	$ 13,279.000 Millions	$ 1,728.250 Millions
Becton Dickinson And Company	7.68	$ 17,412.000 Millions	$ 2,267.500 Millions
Cardiovascular Systems Inc	7.64	$ 262.233 Millions	$ 34.334 Millions
Radnet Inc	7.59	$ 1,164.193 Millions	$ 153.397 Millions
Edwards Lifesciences Corporation	7.59	$ 4,483.700 Millions	$ 590.950 Millions

Date modified: 2026-09-02T20:16:03+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.